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distal aorta and peripheral arterial occlusive disease have fre-
quently selected patients who already had signs of peripheral
arterial occlusive disease and so were prone to selection bias.
Precise estimates of the relationship between aortic hypopla-
sia and peripheral arterial occlusive disease are lacking.
To answer the question of whether aortic diameter is
associated with peripheral arterial occlusive disease, we
conducted a cross-sectional study to assess the association
between distal aortic diameter and peripheral arterial occlu-
sive disease in patients with clinically manifest vascular dis-
ease and patients treated for cardiovascular risk factors.
METHODS
Patients and study design. Patients included in the
Second Manifestations of ARTerial Disease (SMART)
Study were included in the present analyses. The SMART
study is an ongoing prospective cohort study, started at
the Vascular Center of the University Medical Center
Utrecht in September 1996. All eligible patients, aged 18
to 79 years, were newly referred to the hospital with ath-
erosclerotic cardiovascular disease, including transient
ischemic attack, minor stroke, peripheral arterial occlusive
disease, diabetic foot, abdominal aortic aneurysm, angina
pectoris, myocardial infarction, and renal artery stenosis,
or for treatment of cardiovascular risk factors, including
hyperlipidemia, diabetes mellitus, hypertension, and renal
insufficiency. Definitions of the diseases qualifying for
enrollment are reported elsewhere.8 Excluded were
Results of previous studies suggest that distal aortic
diameter plays a role in the development of peripheral
arterial occlusive disease. It has been shown that as much
as 40% of patients with abdominal aortic aneurysms have
peripheral arterial occlusive disease.1-3 Studies that
focused on hypoplasia of the distal aorta, as found in the
small aortic syndrome, also reported an association with
peripheral arterial occlusive disease.4-7
As opposed to studies on aortic aneurysms, the studies
on aortic hypoplasia are scarce and there is no generally
accepted definition of aortic hypoplasia. Furthermore, stud-
ies investigating the relationship between hypoplasia of the
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Objective: Several studies have reported an association between abdominal aortic dilatation and peripheral arterial occlu-
sive disease. Narrowing of aortic diameter, also called abdominal aortic hypoplasia, and peripheral arterial occlusive dis-
ease have received insufficient attention. Precise estimates of the relationship between aortic hypoplasia and peripheral
arterial occlusive disease are lacking. In this study, we assessed the relationship between abdominal aortic diameter and
peripheral arterial occlusive disease.
Methods: In this cross-sectional study, we analyzed 1572 patients 18 to 79 years of age, newly referred to the vascular
center of our hospital with clinically manifest atherosclerotic arterial disease or for treatment of cardiovascular risk fac-
tors. Diameter measurements were used to subdivide patients according to tertiles of abdominal aortic diameter.
Peripheral arterial occlusive disease was assessed by adjusted Rose questionnaire, ankle-brachial pressure index, and the
presence of gangrene or leg ulcers.
Results: Compared with patients with normal aortic diameter, peripheral arterial occlusive disease was twice as preva-
lent in patients at both ends of the aortic diameter spectrum. When the lowest tertile was compared with the middle
tertile in male patients, the adjusted odds ratio was 1.7 (95% CI, 1.0-3.1). When the highest tertile was compared with
the middle tertile, the adjusted odds ratio was 2.1 (95% CI, 1.2-3.4). Similar results were found in female patients. The
adjusted odds ratio of lowest versus middle tertile was 2.4 (95% CI, 1.1-5.0) and 1.8 (95% CI, 0.8-4.0) when the high-
est tertile was compared with the middle tertile.
Conclusion: The risk of peripheral arterial occlusive disease was increased in the lower and upper distribution of aortic
diameter. Apparently, both patients with an aortic diameter too large and patients with an aortic diameter too small are
prone to peripheral arterial occlusive disease. This is the first large study that shows that small aortic diameter is asso-
ciated with peripheral arterial occlusive disease. (J Vasc Surg 2001;34:1085-9.)
patients with terminal malignancy and patients not suffi-
ciently fluent in Dutch. The study was approved by the
ethics committee of the hospital, and all patients gave
written informed consent. The first objectives of the
SMART study were to determine the prevalence of con-
comitant arterial disease at other sites and risk factors in all
patients and to study the incidence of future cardiovascu-
lar events and their predictors. We used the baseline data
of SMART patients and conducted a cross-sectional study
to assess the relationship between distal aortic diameter
and lower-extremity ischemia in this population.
Data collection. We used data from the first 1768
patients who were enrolled in the SMART study. One hun-
dred seventy-four patients referred for abdominal aortic
aneurysm were excluded because they were a priori
selected on aortic diameter. Subsequently, 22 patients were
excluded because the abdominal aorta was heavily calcified
and ultrasound scan measurement of the aortic diameter
could not be performed. A total of 1572 patients, aged 18
to 79 years, was finally included for analysis. Patients
underwent baseline examinations, including a question-
naire on cardiovascular disease, height, weight, and blood
pressure measurements, blood tests, ultrasound scanning
of the abdominal aorta and carotid arteries, and a treadmill
test to assess atherosclerosis of the leg arteries.8
We categorized smokers as current, past, or never.
Body mass index was calculated as body weight divided
by height squared (kg/m2). Hypertension was defined
by a systolic blood pressure ≥160 mm Hg or diastolic
blood pressure ≥95 mm Hg or use of an antihypertensive
medication. Hypercholesterolemia was defined by a
serum total cholesterol ≥6.5 mmol/L or use of choles-
terol-lowering medication. Diabetes mellitus was defined
by fasting serum glucose ≥7.0 mmol/L or nonfasting
serum glucose ≥11.1 mmol/L, or use of glucose-lower-
ing medication.
Measurement of the aortic diameter. Ultrasound
scanning was carried out using an HDI 3000 scanner (ATL,
Bothell, Wash) equipped with transducers of 2-MHz and 
5-MHz, respectively. The ultrasound scan assessment of the
aortic diameters was performed by trained examiners.
Luminal size of the abdominal aorta was measured 10 mm
above the bifurcation. All diameter measurements were per-
formed anteroposteriorly. The echo-free lumen of the ves-
sels was measured between the inner trailing edge of the
anterior wall and the inner edge of the posterior wall. The
measurements were performed in both transverse and lon-
gitudinal sections, taking special care to perform all diame-
ter measurements perpendicular to the long axis of the
vessel. To reduce machine variability, all measurements were
performed with the same scanner.
Indicators and definition of peripheral arterial
occlusive disease. In this cross-sectional study we used the
following indicators of peripheral arterial occlusive disease9:
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Table I. Adjusted Rose questionnaire
Questions Answer
1. Do you get pain in one or both legs when walking? Yes*/No
2a. Pain includes calf/calves? Yes*/No
2b. Pain includes upper leg? Yes/No
2c. Pain includes buttock? Yes/No
2d. Pain located elsewhere in leg? Yes/No
3. Do you get pain when you walk uphill or hurry? Yes*/No
4. Do you get pain when you walk level at an ordinary pace? Yes/No
5. Does the pain ever disappear while you continue walking? Yes/No*
6. What do you do if you get pain when you are walking? Stop*/Continue
7. What happens to the pain if you stop walking? Relieved*/Not relieved
8. How soon? ≤10 min*/>10 min
9. Does the pain ever begin when you are at rest? Yes/No*
*If questions 1, 2a, 3, and 5 through 9 are answered in the manner designated by the asterisk, the adjusted algorithm is positive and the symptoms of the
patient are classified as intermittent claudication.
Table II. Characteristics of the study population*
Total 1572
Referral diagnosis (%)
Transient ischemic attack or minor 22
ischemic stroke
Coronary ischemia 21
Peripheral arterial occlusive disease 20
Renal artery stenosis 1




Age (y) 56 (18-79)
Male sex (%) 66
Body mass index (kg/m2) 26 (16-55)
Smoking past or current (%) 75
Hypertension (%)† 48
Hypercholesterolemia (%)‡ 86
Diabetes mellitus (%)§ 27
*Values are percentages or medians with range in parentheses.
†Systolic pressure ≥160 mmHg, diastolic pressure ≥95 mm Hg, or taking
antihypertensive drugs.
‡Total cholesterol ≥6.5 mmol/L, triglycerides ≥2.3 mmol/L, high-den-
sity–lipoprotein cholesterol ≤1.0 mmol/L, or taking lipid-lowering drugs.
§Fasting serum glucose ≥7.0 mmol/L, nonfasting serum glucose ≥11.1
mmol/L, or taking insulin therapy/oral blood sugar–lowering drugs.
1. Intermittent claudication was present if the algorithm
of the adjusted Rose questionnaire was positively
answered, such as the following: patient gets pain in
one or both legs on walking, the pain includes
calf/calves, pain when walking uphill or in a hurry, the
pain does not disappear while walking, pain disappears
within 10 minutes after termination of walking, and
there is no pain at rest (Table I).10
2. Presence of atherosclerosis in the leg arteries was eval-
uated by measuring the ankle-brachial pressure index
(ABPI) at rest. The systolic blood pressure in the pos-
terior tibial and dorsal pedal arteries (left and right)
was measured with an 8-MHz continuous-wave
Doppler probe connected to an IMEXLAB 9000
Vascular Diagnostic System (Imex Medical Systems,
Golden, Colo) and in both brachial arteries with a
semiautomatic oscillometric device (Omega 1400, In
Vivo Research Laboratories, Broken Arrow, Okla).
For analysis, the lowest resting ABPI of both legs of
each patient was calculated and dichotomized as
abnormal ABPI (≤0.90) and normal ABPI (>0.90).
3. Presence of gangrene or arterial ulcers in one or both
legs, reported by the patient in the questionnaire at
time of referral to the vascular center, was a third indi-
cator.
In this study, peripheral arterial occlusive disease was
defined as presence of intermittent claudication, gangrene,
or arterial ulcers, or a resting ankle-brachial pressure of
0.90 or less in one or both legs.
Statistical analysis. Aortic diameter was assessed as a
continuous variable and expressed in millimeters. To assess
the prevalence of peripheral arterial occlusive disease
according to aortic size, aortic diameters were subse-
quently subdivided into tertiles. Because aortic diameter is
influenced by gender, with men having larger diameters
than women, tertiles were separately calculated for male
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and female patients.11 To evaluate the association between
peripheral arterial occlusive disease and abdominal aortic
diameter, multiple logistic regression models were used.
Odds ratios and 95% confidence intervals (CI) were calcu-
lated for the lowest and highest tertile and compared with
the reference, the middle tertile. Adjustment was made for
factors related to both aortic diameter and risk of periph-
eral arterial occlusive disease. Increased age and increased
body mass index are related to increased aortic diameter
and increased risk of peripheral arterial occlusive disease.
For this reason, adjustment for these two factors was
made. In addition, odds ratios were adjusted for putative
confounders, ie, smoking, hypercholesterolemia, diabetes,
and hypertension.
RESULTS
Table I presents the adjusted Rose questionnaire.
Intermittent claudication was present if questions 1, 2a,
3, and 5 through 9 were positively answered. Based on
the questionnaire, 150 patients (10%) were classified as
having intermittent claudication, 105 men (10%) and 45
women (9%).
Referral diagnosis and characteristics of the partici-
pants are shown in Table II. Age of the 1572 patients var-
ied between 18 and 79 years (median, 56 years), and 66%
of the patients were men. The prevalence of traditional
cardiovascular risk factors was high in the study popula-
tion; 75% of the patients were current or past smokers,
48% were hypertensive, 86% had hypercholesterolemia,
and 27% had diabetes mellitus.
Table III shows the indicators of peripheral arterial
occlusive disease according to tertile of the abdominal aor-
tic diameter in 1039 male and 533 female patients.
Compared with their incidence in patients of the middle
tertile, intermittent claudication, a resting ABPI ≤0.90, and
presence of gangrene or leg ulcers were all more prevalent
Table III. Indicators of peripheral arterial occlusive disease according to tertile of abdominal aortic diameter in
patients*
Lowest tertile Middle tertile Highest tertile
Men n = 314 n = 325 n = 400
Tertile range (mm) 8.0-15.9 mm 16.0-17.9 mm 18.0-63.0 mm‡
Mean age (y) (range) 53 (19-78) 55 (18-79) 61 (24-79)
Intermittent claudication† 32 (10) 18 (6) 55 (14)
Resting ABPI ≤0.90 86 (27) 57 (18) 119 (30)
Gangrene/ulcers 24 (8) 21 (6) 24 (6)
At least one of above 105 (33) 75 (23) 141 (35)
Women n = 178 n = 199 n = 156
Tertile range (mm) 8.0-13.0 mm 13.1-15.0 mm 15.1-50.0 mm§
Mean age (y) (range) 51 (18-77) 54 (19-79) 59 (27-79)
Intermittent claudication† 19 (11) 10 (5) 16 (10)
Resting ABPI ≤ 0.90 49 (28) 48 (24) 49 (31)
Gangrene/ulcers 16 (9) 10 (5) 9 (6)
At least one of the above 61 (34) 56 (28) 57 (37)
*Percentages are given in parentheses except where otherwise indicated.
†Positive adjusted Rose algorithm.
‡Aortic diameter 30.0-55.0 mm, n = 30. Aortic diameter > 55.0 mm, n = 3.
§Aortic diameter 30.0-55.0 mm, n = 1.
in patients of the lowest tertile. A similar association was
found when the highest tertile was compared with the mid-
dle tertile; male and female patients of the highest tertile
presented signs of lower-extremity ischemia more often.
Table IV presents the adjusted odds ratios reflecting
the strength of the association between peripheral arterial
occlusive disease and aortic diameter in male and female
patients. Peripheral arterial occlusive disease in male
patients was more prevalent in the lowest tertile.
Compared with that of the middle tertile, the adjusted
odds ratio was 1.7 (95% CI, 1.0-3.1). When the highest
tertile was compared with the middle tertile, peripheral
arterial occlusive disease was more prevalent in the highest
tertile; the adjusted odds ratio was 2.1 (95% CI, 1.2-3.4).
Similar results were found in female patients. When
the lowest tertile was compared with the middle tertile,
the adjusted odds ratio was 2.4 (95% CI, 1.1-5.0).
Compared with that of the middle tertile, peripheral arte-
rial occlusive disease was also more prevalent in the high-
est tertile; the adjusted odds ratio was 1.8 (95% CI,
0.8-4.0). The results did not change after additional
adjustment for atherosclerotic risk factors, ie, smoking,
hypercholesterolemia, diabetes, and hypertension.
DISCUSSION
The abdominal aortic diameter is normally distributed
and represents a continuum of sizes in which patients with a
small diameter and patients with a large diameter represent
the ends of this continuum.11-13 Compared with patients
with a normal aortic diameter, peripheral arterial occlusive
disease was twice as prevalent in patients at both ends of this
aortic diameter spectrum and was equally distributed in men
and women. Apparently, both patients with an aortic diam-
eter too large and patients with an aortic diameter too small
are prone to peripheral arterial occlusive disease. It is possi-
ble that in these patients, abnormal aortic diameters induce
hemodynamic changes that could result in vessel-wall dam-
age and so cause peripheral arterial occlusive disease.
In this study, peripheral arterial occlusive disease was
defined as the presence of intermittent claudication, gan-
grene, or arterial ulcers, or a resting ABPI of 0.90 or less
in one or both legs. In each tertile, there was a significant
difference between the number of patients with a resting
ABPI ≤0.90 and the number that actually had intermittent
claudication. This discrepancy indicates that there is a por-
tion of patients with low ABPI without symptoms.
However, results of previous studies have already pointed
out that low ABPI is not automatically related to symp-
toms of intermittent claudication.9
The relationship between aortic diameter and periph-
eral arterial occlusive disease may have considerable impli-
cations for the risk management of these patients. Control
of conventional risk factors (smoking, hypertension, dia-
betes, and hypercholesterolemia) may be particularly
important in these patients. We believe that determination
of abdominal aortic diameter by ultrasound scan should be
considered as a part of total risk profile assessment. In this
way patients at high risk could be identified.
The association between abdominal aortic aneurysm
and peripheral arterial occlusive disease is well known and
is found in about 20% to 40% of patients with abdominal
aortic aneurysms.1-3 In 1988, Allerdice et al2 screened the
abdominal aorta in 100 patients with peripheral arterial
occlusive disease and in 100 controls. The incidence of
abdominal aortic aneurysm in the patient group was 20%,
as compared with 2% in the control group.2 More recently,
Kanagasabay et al14 compared patients with abdominal
aortic aneurysm with patients with a normal aortic diame-
ter and concluded that patients with aortic aneurysm pre-
sented symptoms of lower-extremity ischemia more often.
Our results are consistent with these findings.
The association between aortic hypoplasia and periph-
eral arterial occlusive disease was also reported in several
studies.4-7 However, most of these studies were hampered
by methodologic problems such as lack of a good defini-
tion of hypoplasia and selection bias. Hypoplasia of the
abdominal aorta is known in the literature under many dif-
ferent names, such as small aortic syndrome, atresia of the
aorta, and hypoplastic aorta iliac syndrome, frequently
meaning slightly different, not well-defined disease enti-
ties. There is not a single definition of hypoplasia of the
abdominal aorta, nor is it known how it should be mea-
sured.15-24 Clemetson et al6 defined aortic hypoplasia as a
corrected internal diameter of 12.5 mm or less measured
on angiogram but did not indicate where the measure-
ment had to be done. Shin et al24 defined hypoplasia as an
aortic diameter of 10 to 12 mm measured by computed
tomography 1 cm below the orifice of the superior mesen-
teric artery.24 None of these studies took into account the
normal distribution of aortic diameter, nor did they dif-
ferentiate between men and women. Only Cronenwett et
al13 recognized this and defined a small aorta by using the
aortic diameter minus one standard deviation below over-
all mean measured on angiogram in a population of
women with atherosclerotic disease.
Another methodologic problem is selection bias. Most
studies on aortic hypoplasia were done in a selected popu-
lation with peripheral arterial occlusive disease, because
angiograms on which the measurements to assess hypopla-
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Table IV. Odds ratios (95% CI) for peripheral arterial
occlusive disease in relation to tertiles of the aortic
diameter*
Crude OR Adjusted OR†
Male patients
First vs second tertile 1.8 (1.0-3.2) 1.7 (1.0-3.1)
Third vs second tertile 2.2 (1.3-3.7) 2.1 (1.2-3.4)
Female patients
First vs second tertile 2.2 (1.1-4.6) 2.4 (1.1-5.0)
Third vs second tertile 2.0 (1.0-4.2) 1.8 (0.8-4.0)
*Peripheral arterial occlusive disease was defined as presence of lifestyle-
limiting intermittent claudication, gangrene, or ulcers, or a resting ABPI of
less than 0.90 in one or both legs.
†Adjusted for age and body mass index.
OR, Odds ratio.
sia were done were nearly always made because of periph-
eral arterial occlusive disease. This means that an association
between hypoplasia and peripheral arterial occlusive disease
is always found. Only recently have noninvasive diagnostic
tests such as ultrasound scan made it possible to investigate
aortic diameter in larger populations that are not a priori
selected on peripheral arterial occlusive disease.
In our study, we used ultrasound scan to investigate a
population with severe atherosclerotic disease that was not
selected on peripheral arterial occlusive disease. To avoid
definition problems, we divided the patient group into ter-
tiles and compared the highest and lowest tertiles with the
middle tertile. Furthermore, we could differentiate between
the diameters of men and women. In this way, our study
showed that the association between aortic hypoplasia and
peripheral arterial occlusive disease did not differ between
men and women, although much literature has suggested
this. Because overall aortic diameter in women is smaller
than in men, women tend to be over-represented when sin-
gle absolute cutoff values are taken to define hypoplasia.
In conclusion, both small and large aortic diameters
are associated with peripheral arterial occlusive disease.
The results regarding small aortic diameter are new. This
is the first large study that shows that small aortic diame-
ter is associated with peripheral arterial occlusive disease in
a population of patients with risk factors or clinically man-
ifest vascular disease. Because aortic diameter is influenced
by age, sex, and body mass index, it is difficult to define
precise criteria for aortic hypoplasia. We concluded that
the entity hypoplasia is one extreme of a continuous spec-
trum, as is the entity aneurysm at the other extreme.
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